News
News Medical on MSN8d
Understanding resistance to EGFR targeted therapies in head and neck cancers and breast cancerA new review was published in Volume 16 of Oncotarget on June 25, 2025, titled "Challenges and resistance mechanisms to EGFR ...
WILMINGTON, DE — The U.S. Food and Drug Administration (FDA) has granted accelerated approval to DATROWAY® (datopotamab deruxtecan-dlnk) for the treatment of adult patients with locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback